Strata Critical Medical (SRTA) CAO uses 2,433 shares for taxes

Rhea-AI Filing Summary

Strata Critical Medical, Inc. Chief Accounting Officer Amir Cohen reported a routine tax-withholding transaction. The issuer withheld 2,433 shares of Class A common stock at $4.54 per share to satisfy taxes on vested restricted stock units, and Cohen now directly holds 179,384 shares.

Insider Trade Summary

Net Seller: 2,433 shares

Net Sell 1 txn

Insider Cohen Amir

Role Chief Accounting Officer

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Class A common stock, $0.0001 par value per share	2,433	$4.54	$11K

Holdings After Transaction: Class A common stock, $0.0001 par value per share — 179,384 shares (Direct)

Footnotes (1)

1. F1. Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

FAQ

What insider transaction did Strata Critical Medical (SRTA) report for Amir Cohen?

Strata Critical Medical reported that Chief Accounting Officer Amir Cohen had 2,433 shares of Class A common stock withheld. The shares were used to satisfy tax withholding obligations tied to the vesting of restricted stock units, rather than an open-market sale.

Was the Strata Critical Medical (SRTA) Form 4 transaction an open-market sale?

No, the Form 4 transaction was not an open-market sale. It reflects shares withheld by the company to cover tax obligations from restricted stock unit vesting, classified as a tax-withholding disposition under code F, not a discretionary sale by the insider.

How many shares were involved in Amir Cohen’s Strata Critical Medical (SRTA) tax withholding?

The filing shows 2,433 shares of Class A common stock withheld at $4.54 per share. These shares were retained by the issuer to pay Cohen’s tax obligations related to vesting restricted stock units, reducing his holdings by that amount in a non-market transaction.

How many Strata Critical Medical (SRTA) shares does Amir Cohen hold after this Form 4?

After the tax-withholding transaction, Amir Cohen directly holds 179,384 shares of Strata Critical Medical Class A common stock. This figure reflects his position following the 2,433 shares withheld by the issuer to satisfy tax obligations associated with restricted stock unit vesting.

What does transaction code F mean in the Strata Critical Medical (SRTA) Form 4?

Transaction code F indicates a payment of exercise price or tax liability by delivering or withholding securities. In this case, 2,433 shares were withheld by Strata Critical Medical to cover taxes on vested restricted stock units for Chief Accounting Officer Amir Cohen.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 03/10/2026 - 05:29 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cohen Amir

(Last) (First) (Middle)

C/O STRATA CRITICAL MEDICAL, INC.

31 HUDSON YARDS, 14TH FLOOR

(Street)

NEW YORK NY 10001

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Strata Critical Medical, Inc. [ SRTA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Accounting Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/08/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A common stock, $0.0001 par value per share	03/08/2026		F		2,433(1)	D	$4.54	179,384	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Remarks:

	/s/ Melissa M. Tomkiel, Attorney-in-fact for Amir Cohen	03/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.